These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 22219475

  • 1. A dose-response study of levosimendan in a porcine model of acute ischaemic heart failure.
    Kolseth SM, Wahba A, Kirkeby-Garstad I, Aro S, Nordgaard H, Høydal M, Rognmo Ø, Nordhaug D.
    Eur J Cardiothorac Surg; 2012 Jun; 41(6):1377-83. PubMed ID: 22219475
    [Abstract] [Full Text] [Related]

  • 2. Direct myocardial effects of levosimendan in humans with left ventricular dysfunction: alteration of force-frequency and relaxation-frequency relationships.
    Givertz MM, Andreou C, Conrad CH, Colucci WS.
    Circulation; 2007 Mar 13; 115(10):1218-24. PubMed ID: 17339544
    [Abstract] [Full Text] [Related]

  • 3. Levosimendan improves right ventriculovascular coupling in a porcine model of right ventricular dysfunction.
    Missant C, Rex S, Segers P, Wouters PF.
    Crit Care Med; 2007 Mar 13; 35(3):707-15. PubMed ID: 17255859
    [Abstract] [Full Text] [Related]

  • 4. Zatebradine, a specific bradycardic agent, alters the hemodynamic and left ventricular mechanical actions of levosimendan, a new myofilament calcium sensitizer, in conscious dogs.
    Pagel PS, Harkin CP, Hettrick DA, Warltier DC.
    J Pharmacol Exp Ther; 1995 Oct 13; 275(1):127-35. PubMed ID: 7562540
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The effects of levosimendan on myocardial function in ropivacaine toxicity in isolated guinea pig heart preparations.
    Stehr SN, Christ T, Rasche B, Rasche S, Wettwer E, Deussen A, Ravens U, Koch T, Hübler M.
    Anesth Analg; 2007 Sep 13; 105(3):641-7. PubMed ID: 17717217
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Orally available levosimendan dose-related positive inotropic and lusitropic effect in conscious chronically instrumented normal and heart failure dogs.
    Masutani S, Cheng HJ, Hyttilä-Hopponen M, Levijoki J, Heikkilä A, Vuorela A, Little WC, Cheng CP.
    J Pharmacol Exp Ther; 2008 Apr 13; 325(1):236-47. PubMed ID: 18174383
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Milrinone and levosimendan during porcine myocardial ischemia -- no effects on calcium overload and metabolism.
    Axelsson B, Johansson G, Abrahamsson P, Gupta A, Tydén H, Wouters P, Haney M.
    Acta Anaesthesiol Scand; 2013 Jul 13; 57(6):719-28. PubMed ID: 23517167
    [Abstract] [Full Text] [Related]

  • 13. Ca2+ sensitizer superior to catecholamine during myocardial stunning?
    Meyer K, Klocke RC, Schipke JD, Gams E, Korbmacher B.
    Eur J Cardiothorac Surg; 2008 Aug 13; 34(2):326-31. PubMed ID: 18539040
    [Abstract] [Full Text] [Related]

  • 14. Levosimendan cardioprotection reduces the metabolic response during temporary regional coronary occlusion in an open chest pig model.
    Metzsch C, Liao Q, Steen S, Algotsson L.
    Acta Anaesthesiol Scand; 2007 Jan 13; 51(1):86-93. PubMed ID: 17073861
    [Abstract] [Full Text] [Related]

  • 15. Levosimendan enhances left ventricular systolic and diastolic function in conscious dogs with pacing-induced cardiomyopathy.
    Pagel PS, McGough MF, Hettrick DA, Lowe D, Tessmer JP, Jamali IN, Warltier DC.
    J Cardiovasc Pharmacol; 1997 May 13; 29(5):563-73. PubMed ID: 9213196
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Systemic and coronary hemodynamic actions and left ventricular functional effects of levosimendan in conscious dogs.
    Harkin CP, Pagel PS, Tessmer JP, Warltier DC.
    J Cardiovasc Pharmacol; 1995 Aug 13; 26(2):179-88. PubMed ID: 7475041
    [Abstract] [Full Text] [Related]

  • 18. Mechanisms of a reduced cardiac output and the effects of milrinone and levosimendan in a model of infant cardiopulmonary bypass.
    Stocker CF, Shekerdemian LS, Nørgaard MA, Brizard CP, Mynard JP, Horton SB, Penny DJ.
    Crit Care Med; 2007 Jan 13; 35(1):252-9. PubMed ID: 17133188
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Inotropic, vasodilating and preconditioning actions of levosimendan in the heart.
    Meyer K, Schipke JD, Klocke RC, Gams E, Korbmacher B.
    Thorac Cardiovasc Surg; 2008 Oct 13; 56(7):379-85. PubMed ID: 18810693
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.